Cargando…

Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China

A resurgence of the mumps epidemic in highly vaccinated populations has occurred in recent years in many countries. This study aimed to evaluate the seroprevalence to mumps in urban areas of Shanghai, where a measles-mumps-rubella (MMR) vaccination had been implemented for 20 years. Mumps IgG antibo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Hong, Zhou, Yibiao, Zhao, Wensui, Jiang, Qingwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210938/ https://www.ncbi.nlm.nih.gov/pubmed/30249033 http://dx.doi.org/10.3390/ijerph15102089

Ejemplares similares

Epidemiological changes in mumps infections between 1990 and 2017 in urban area of Shanghai, China
por: Pang, Hong, et al.
Publicado: (2020)

Seroprevalence of Antibodies to Measles, Mumps, and Rubella among Thai Population: Evaluation of Measles/MMR Immunization Programme
por: Tharmaphornpilas, Piyanit, et al.
Publicado: (2009)

Mumps: MMR vaccination and genetic diversity of mumps virus, 2007–2011 in Catalonia, Spain
por: Barrabeig, Irene, et al.
Publicado: (2019)

Are Measles-Mumps-Rubella (MMR) Antibodies Friends or Foes for Covid-19 Disease?
por: Salamony, Azza, et al.
Publicado: (2023)

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
por: Quach, Huy Quang, et al.
Publicado: (2022)

Improving health literacy with mumps, measles and rubella (MMR) vaccination: comparison of the readability of MMR patient-facing literature and MMR scientific abstracts
por: Downey, Tina, et al.
Publicado: (2022)

Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients
por: Casale, Maddalena, et al.
Publicado: (2021)

Measles, Mumps, and Rubella Antibody: Patterns of Persistence and Rate of Decline Following the Second Dose of the MMR Vaccine
por: Seagle, Emma, et al.
Publicado: (2017)

Anticancer Activity of Measles–Mumps–Rubella MMR Vaccine Viruses against Glioblastoma
por: Khalid, Zumama, et al.
Publicado: (2023)

Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer
por: Marquis, Sara R., et al.
Publicado: (2021)

Low vaccine efficacy of mumps component among MMR vaccine recipients in Chennai, India
por: Malaiyan, Jeevan, et al.
Publicado: (2014)

Factors associated with uptake of Haemophilus influenzae type b vaccination in Shanghai, China
por: Yang, Ya, et al.
Publicado: (2019)

Establishment of a standard seed lot system of an Iranian Mumps virus strain; RS-12, for mass production of mumps and MMR vaccines
por: Shahkarami, M K, et al.
Publicado: (2012)

Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
por: Gold, Jeffrey E., et al.
Publicado: (2020)

The emergence of mumps after the COVID-19 pandemic in Pakistan: Time to consider MMR vaccination strategies
por: Rana, Muhammad Suleman, et al.
Publicado: (2023)

2763. Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink
por: Hanson, Kayla E, et al.
Publicado: (2019)

An Economic Analysis of Mumps Vaccination in Fiji: Static Model Simulation of Routine Measles–Mumps–Rubella (MMR) Vaccination Instead of Current Measles–Rubella (MR) Vaccination
por: Oh, Chunghyeon, et al.
Publicado: (2022)

Long time persistence of antibodies against Mumps in fully MMR immunized young adults: an Italian retrospective cohort study
por: Bianchi, Francesco Paolo, et al.
Publicado: (2020)

Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program
por: dos Santos, Eliane Matos, et al.
Publicado: (2014)

Relationship Between Media Coverage and Measles-Mumps-Rubella (MMR) Vaccination Uptake in Denmark: Retrospective Study
por: Hansen, Niels Dalum, et al.
Publicado: (2019)

Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants
por: Cho, Hye-Kyung, et al.
Publicado: (2016)

Association of Daily Exposure to Air Pollutants with the Risk of Tuberculosis in Xuhui District of Shanghai, China
por: Xiong, Ying, et al.
Publicado: (2022)

Seroprevalence of mumps in healthcare workers in South Korea
por: Kim, Sun-Kyung, et al.
Publicado: (2020)

A Study to Evaluate the Role of Intradermal and Intralesional Measles, Mumps, Rubella (MMR) Vaccine in Treatment of Common Warts
por: Gupta, Pragya, et al.
Publicado: (2020)

Lessons Learned from Publicizing and Retracting an Erroneous Hypothesis on the Mumps, Measles, Rubella (MMR) Vaccination with Unethical Implications
por: Khan, Hiba, et al.
Publicado: (2021)

Low rate of seropositivity (IgG) to mumps component in MMR vaccinees in Chennai, south India
por: Malaiyan, Jeevan, et al.
Publicado: (2014)

Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
por: Lebo, Emmaculate J., et al.
Publicado: (2015)

Analysis of the spatial distribution of Aedes albopictus in an urban area of Shanghai, China
por: Zhou, Yibin, et al.
Publicado: (2021)

Does Measles, Mumps, and Rubella (MMR) Vaccination Protect against COVID-19 Outcomes: A Nationwide Cohort Study
por: Kolla, Epiphane, et al.
Publicado: (2022)

Addressing issues of vaccination literacy and psychological empowerment in the measles-mumps-rubella (MMR) vaccination decision-making: a qualitative study
por: Fadda, Marta, et al.
Publicado: (2015)

Missed Opportunities for Measles, Mumps, and Rubella (MMR) Immunization in Mesoamerica: Potential Impact on Coverage and Days at Risk
por: Mokdad, Ali H., et al.
Publicado: (2015)

Seroprevalence of measles, mumps, rubella, and varicella-zoster antibodies in new female nurses in the Republic of Korea
por: Yoo, Yeongjae, et al.
Publicado: (2021)

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands
por: Tielemans, Susanne M A J, et al.
Publicado: (2017)

571. A Report of the Postmarketing Spontaneous Safety Data over 24 Years for GSK’s Measles-Mumps-Rubella (MMR) Vaccine
por: Singh, Tina, et al.
Publicado: (2022)

Municipality-level measles, mumps, and rubella (MMR) vaccine coverage and deprivation in Brazil: A nationwide ecological study, 2006 to 2020
por: Godin, Audrey, et al.
Publicado: (2023)

1209. Seroprevalence of Measles, Mumps, and Rubella in Korean Healthcare Workers and Strategy for Vaccination
por: Ju Choo, Eun, et al.
Publicado: (2019)

1076. Gaps in Measles and Mumps Seroprevalence Among Cancer Patients
por: Marquis, Sara, et al.
Publicado: (2020)

1077 Adverse events following measles, mumps, and rubella (MMR) vaccine in adults reported to the Vaccine Adverse Event Reporting System, 2003-2013
por: Sukumaran, Lakshmi, et al.
Publicado: (2014)

Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for Seronegativity
por: Poethko-Müller, Christina, et al.
Publicado: (2012)

Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing
por: Meng, Qing-hong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q9u9765lrpfhhhmmgsa8brsmqg